Onderzoeker
Yves Briers
- Disciplines:Engineering van biomaterialen, Biologische systeemtechnologie, Biomateriaal engineering, Biomechanische ingenieurswetenschappen, Andere (bio)medische ingenieurswetenschappen, Milieu ingenieurswetenschappen en biotechnologie, Industriële biotechnologie, Andere biotechnologie, bio-en biosysteem ingenieurswetenschappen
Affiliaties
- Departement Biosystemen (Departement)
Lid
Vanaf1 aug 2005 → 30 apr 2015
Projecten
1 - 3 of 3
- Ontwikkeling van de nieuwste generatie Artilysines, enzyme-gebaseerde antibiotica tegen multidrug-resistente bacteriënVanaf1 jan 2015 → 30 apr 2015Financiering: FWO Krediet aan Navorser
- Ontwikkeling van de tweede generatie vancomycine-gebaseerde antibioticaVanaf1 apr 2014 → 31 aug 2015Financiering: IOF - Industrieel Onderzoeksfonds
- Studie en exploitatie van bacteriofaaggecodeerde endolysines en exopolysaccharide depolymerasen.Vanaf1 okt 2008 → 31 dec 2008Financiering: BOF - Andere acties
Publicaties
11 - 20 van 34
- Role of the Pre-neck Appendage Protein (Dpo7) from Phage vB_SepiS-phiIPLA7 as an Anti-biofilm Agent in Staphylococcal Species(2015)
Auteurs: Yves Briers, Rob Lavigne
- Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm (vol 10, e0127603, 2015)(2015)
Auteurs: Kasia Danis - Wlodarczyk, Tomasz Olszak, Michal Arabski, Slawomir Wasik, Grazyna Majkowska-Skrobek, Daria Augustyniak, Grzegorz Gula, Yves Briers, Ho Bin Jang, Dieter Vandenheuvel, et al.
- Metabolite profiling and peptidoglycan analysis of transient cell wall-deficient bacteria in a new Escherichia coli model system(2015)
Auteurs: Alexander Cambré, Bram Vivijs, William Cenens, Chris Michiels, Abram Aertsen, Rob Lavigne, Yves Briers
Pagina's: 1586 - 1599 - Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria(2015)
Auteurs: Yves Briers, Rob Lavigne
Pagina's: 377 - 90 - Two Complete and One Draft Genome Sequence of Nonproteolytic Clostridium botulinum Type E Strains NCTC 8266, NCTC 8550, and NCTC 11219(2015)
Auteurs: Charlien Clauwers, Yves Briers, Rob Lavigne, Chris Michiels
- Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm(2015)
Auteurs: Kasia Danis - Wlodarczyk, Yves Briers, HB Jang, Dieter Vandenheuvel, Rob Lavigne
- The zeamine antibiotics affect the integrity of bacterial membranes(2015)
Auteurs: Joleen Masschelein, Charlien Clauwers, Karen Stalmans, Koen Nuyts, Wim De Borggraeve, Yves Briers, Abram Aertsen, Chris Michiels, Rob Lavigne
Pagina's: 1139 - 1146 - Hurdles in bacteriophage therapy: Deconstructing the parameters(2014)
Auteurs: Jessica Tsonos, Dieter Vandenheuvel, Yves Briers, Henri De Greve, Jean-Pierre Hernalsteens, Rob Lavigne
Pagina's: 460 - 9 - Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa(2014)
Auteurs: Yves Briers, Valerie Defraine, Jan Michiels, William Cenens, Abram Aertsen, Rob Lavigne
Pagina's: 3774 - 3784 - Hurdles in bacteriophage therapy: Deconstructing the parameters(2014)
Auteurs: Dieter Vandenheuvel, Yves Briers, Rob Lavigne
Pagina's: 460 - 9
Patenten
1 - 10 van 10
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- New endolysin obpgplys (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- VANCOMYCIN ANALOGS (Inventor)